FLUOROPHARMA MEDICAL, INC.

(FPMI)
Delayed OTC Markets  -  02:53 2022-07-28 pm EDT
0.003000 USD   -40.00%
06/23FluoroPharma Medical, Inc. Announces Executive Changes
CI
06/23FluoroPharma Medical, Inc. Appoints Frank I Igwealor as CFO
CI
06/23FLUOROPHARMA MEDICAL, INC. : Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt

03/31/2017 EDT

FluoroPharma Medical, Inc. filed its 10-K on Mar 31, 2017 for the period ending Dec 31, 2016. In this report its auditor, Wolf & Company, P.C., gave an unqualified opinion expressing doubt that the company can continue as a going concern.


© S&P Capital IQ 2017
All news about FLUOROPHARMA MEDICAL, INC.
06/23FluoroPharma Medical, Inc. Announces Executive Changes
CI
06/23FluoroPharma Medical, Inc. Appoints Frank I Igwealor as CFO
CI
06/23FLUOROPHARMA MEDICAL, INC. : Changes in Control or Registrant, Change in Directors or Prin..
AQ
2018FluoroPharma Medical, Inc. Restructures CardioPET License With Massachusetts General Ho..
CI
2017FluoroPharma Medical, Inc. cancelled the acquisition of Ground Fluor Pharmaceuticals, I..
CI
2017FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt
CI
2017FluoroPharma Medical, Inc. Announces Resignation of Lawrence Atinsky as Director and Me..
CI
2016FluoroPharma Medical, Inc. Borrows $50,000 in the Form of Promissory Note; Announces Bo..
CI
2016FluoroPharma Medical, Inc. announced that it has received $0.57 million in funding
CI
2016FLUOROPHARMA MEDICAL, INC. (OTCPK : FPMI) entered into a nonbinding letter of intent to ac..
CI
More news
Chart FLUOROPHARMA MEDICAL, INC.
Duration : Period :
FluoroPharma Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Ambrose O Egbuonu President, CEO, Secretary, Treasurer & Director
Frank Ikechukwu Igwealor Chief Financial Officer, Director & Controller
Walter W. Witoshkin Chairman
William Austin Lewis Independent Director
Edward L. Lyons Vice President-Development
Sector and Competitors
1st jan.Capi. (M$)
FLUOROPHARMA MEDICAL, INC.299,900.00%0
MODERNA, INC.-26.44%73 092
IQVIA HOLDINGS INC.-16.94%43 781
LONZA GROUP AG-26.44%43 083
SEAGEN INC.13.72%32 426
ALNYLAM PHARMACEUTICALS, INC.28.89%26 235